References
- 1. European Pharmacopoeia, 8th ed., Vol. 2, Council of Europe, 2014, Strasbourg, France.
- 2. A. K. Nayak and K. Manna, Current developments in orally disintegrating tablet technology, J. Pharm. Educ. Res. 2 (2011) 21-34.
- 3. A. Zajicek, M. J. Fossler, J. S. Barrett, J. H. Worthington, R. Ternik, G. Charkoftaki, S. Lum, J. Breitkreutz, M. Baltezor, P. Macheras, M. Khan, S. Agharkar and D. D. Maclaren, A report from the pediatric formulations task force: perspectives on the state of child-friendly oral dosage forms, The AAPS Journal 15 (2013) 1072-1081; DOI: 10.1208/s12248-013-9511-5.10.1208/s12248-013-9511-5378723723907486
- 4. J. M. Suñé-Negre, M. Roig Carreras, R. Fuster García, C. Hernández Pérez et al., Nueva metodologıa de preformulacion galenica para la caracterizacion de sustancias en relacion a su viabilidad para la compresion: diagrama SeDeM, Cienc. Tecnol. Pharm. 3 (2005) 125-136.
- 5. J. M. Suñé-Negre, P. Pérez Lozano, M. Miñarro, M. Roig, R. Fuster, C. Hernández, R. Ruhí, E. García-Montoya and J. R Ticó, Application of the SeDeM Diagram and new mathematical equation in the design of direct compression tablet formulation, Eur. J. Pharm. Biopharm. 69 (2008) 1029-1039; DOI: 10.1016/j.ejpb.2008.01.020.10.1016/j.ejpb.2008.01.02018367387
- 6. J. E. Aguilar-Díaz, E. García-Montoya, P. Pérez-Lozano, J. M. Suñé-Negre, M. Suñe-Negre, M. Miñarro and J. R. Ticó, The use of the SeDeM Diagram expert system to determine the suitability of diluents-disintegrants for direct compression and their use in formulation of ODT, Eur. J. Pharm. Biopharm. 73 (2009) 414-423; DOI: 10.1016/j.ejpb.2009.07.001.10.1016/j.ejpb.2009.07.00119602435
- 7. J. E. Aguilar-Díaz, E. García-Montoya, J. M. Sũné-Negre, P. Pérez-Lozano, M. Miñarro and J. R. Ticó, Predicting orally disintegrating tablets formulations of ibuprophen tablets: an application of the new SeDeM-ODT expert system, Eur. J. Pharm. Biopharm. 80 (2012) 638-648; DOI: 10.1016/j.ejpb.2011.12.012.10.1016/j.ejpb.2011.12.01222245156
- 8. E. García Montoya, M. Suñé-Negre, P. Pérez Lozano, M. Miñarro Carmona and J. R. Ticó, Metodología de preformulación galénica para la caracterización de sustancias en relación a su viabilidad para la compresión: Diagrama SeDeM, Farmespaña Ind, enero-febrero (2010) 58-62.
- 9. M. Suñé-Negre, P. Pérez-Lozano, M. Roig, R. Fuster, Carmen Hernández, R. Ruhí, E. García-Montoya, M. Miñarro and J. R Ticó, Optimization of parameters of the SeDeM Diagram Expert System: Hausner index (IH) and relative humidity (%RH), Eur. J. Pharm. Biopharm. 79 (2011) 464-472; DOI: 10.1016/j.ejpb.2011.04.002. 10.1016/j.ejpb.2011.04.00221501683
- 10. J. E. Aguilar-Díaz, E. García-Montoya, P. Pérez-Lozano, J. M. Suñé-Negre, M. Miñarro and J. R. Ticó, SeDeM expert system a new innovator tool to develop pharmaceutical forms, Drug Dev. Ind. Pharm. 40 (2014) 222-236; DOI: 10.3109/03639045.2012.756007.10.3109/03639045.2012.75600723343308
- 11. H. Tayebi and S. A. Mortazavi, Formulation and Evaluation of a Novel Matrix-Type Orally Disintegrating Ibuprofen Tablet, Iran J. Pharm. Res. 10 (2011) 469-479.
- 12. A. Gryczke, S. Schminke, M. Maniruzzaman, J. Beck and D. Douroumis, Development and evaluation of orally disintegrating tablets (ODTs) containing Ibuprofen granules prepared by hot melt extrusion, Colloids Surf. B Biointerfaces 86 (2011) 275-284. DOI: 10.1016/j.colsurfb.2011.04.007.10.1016/j.colsurfb.2011.04.00721592751
- 13. United States Pharmacopeia, 32nd Revision, United States Pharmacopeia, 2009, Convention, Inc. Rockville (MD).
- 14. J. E. Aguilar, E. Garcia-Montoya, P. Perez-Lozano, J. M. Suñé-Negre, M. Carmona and J. Grau, Formulation Tools for Pharmaceutical Development, Woodhead Publishing, Philadelphia 2013, pp. 137-154.10.1533/9781908818508.137
- 15. L. X. Liu, I. Marziano, A. C. Bentham, J. D. Litster, E. T. White and T. Howes, Effect of particle properties on the flowability of ibuprofen powders, Int. J. Pharm. 362 (2008) 109-117; DOI: 10.1016/j.ijpharm.2008.06.023.10.1016/j.ijpharm.2008.06.02318652883